鹏华中证医药卫生(LOF)C(010366)财务指标
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
本期已实现收益 |
-2,867,825.61 |
-1,251,819.16 |
-1,752,093.92 |
-407,352.69 |
本期利润 |
-4,148,835.35 |
-6,157,440.44 |
-3,231,006.87 |
-2,077,014.43 |
加权平均基金份额本期利润 |
-0.09 |
-0.13 |
-0.07 |
-0.05 |
本期加权平均净值利润率(%) |
-14.81 |
-22.17 |
-10.48 |
-6.97 |
本期基金份额净值增长率(%) |
-12.48 |
-18.89 |
-10.75 |
-7.21 |
期末可供分配利润 |
-22,017,352.09 |
-22,668,497.00 |
-16,517,039.58 |
-14,503,374.18 |
期末可供分配基金份额利润 |
-0.43 |
-0.47 |
-0.34 |
-0.32 |
期末基金资产净值 |
29,680,961.47 |
25,780,315.81 |
31,450,577.88 |
31,165,943.97 |
期末基金份额净值 |
0.57 |
0.53 |
0.66 |
0.68 |
基金份额累计净值增长率(%) |
-42.59 |
-46.79 |
-34.40 |
-31.80 |